-
Recalled NumbSkin pain relief cream
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
SeeNext Venture toll-free at 844-700-6862 from 9 a.m. to 6 p.m. PT Monday through Saturday, email at distributions@numbskin.com or online at www.numbskin.com and click on Recall at the home page for more information.
Recall Details
This recall involves NumbSkin pain relief cream with 5% lidocaine. The topical anesthetic cream was sold in 30 grams in a white with blue tube. NumbSkin is printed on the tube. Lot 9238 and a date code of 10/2019 through 09/2020 in a MM/YYYY format is embossed on the tub’s thin end. Batch number 9238 is printed on the product packaging.
Consumers should immediately store the pain relief cream in a safe location out of reach of children and contact SeeNext Venture for instructions on how to dispose or return it and to receive a free replacement similar product with a child-resistant cap. Amazon is contacting all known purchasers directly.
None reported.
SeeNext Venture Ltd., of Blaine, Wash.
Note: Individual Commissioners may have statements related to this topic. Please visit www.cpsc.gov/commissioners to search for statements related to this or other topics.
Related Recalls
The recalled dietary supplements contain iron which must be in child-resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child-resistant, posing a risk of poisoning if the contents are swallowed by young children.
The recalled products contain diphenhydramine hydrochloride and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
The cord on the hair stylers can detach if the unit is dropped, posing an electrocution or shock hazard to users.
The products contain sodium hydroxide or potassium hydroxide which must be in child resistant packaging, as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of chemical burns and irritation to the skin and eyes. In addition, the label on the product violates the Federal Hazardous Substance Act (FHSA) by omitting the word “poison” for poisonous chemicals.
The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than $1 trillion annually. CPSC's work to ensure the safety of consumer products has contributed to a decline in the rate of injuries associated with consumer products over the past 50 years.
Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.
- Visit CPSC.gov.
- Sign up to receive our e-mail alerts.
- Follow us on Facebook, Instagram @USCPSC and Twitter @USCPSC.
- Report a dangerous product or product-related injury on www.SaferProducts.gov.
- Call CPSC’s Hotline at 800-638-2772 (TTY 301-595-7054).
- Contact a media specialist.
